A study conducted on patients with severe COVID-19 has shown that in all CP-transfused patients who obtained SARS-CoV-2 serum, an increase in oxygen saturation and lymphocyte counts and an improvement in their liver function and C-reactive protein (CRP) were observed [17,18]. This evidence concerns the gene CRP and COVID-19.